Respiratory adenovirus infections in children: a focus on Africa

Marieke M van der Zalm1, Nadia A Sam-Agudu2,3,4, Lilly M Verhagen1,5,6

  • 1Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

PubMed

Insights

Human adenovirus (HAdV) is a significant cause of severe lower respiratory tract infections (LRTIs) in African children, leading to mortality and long-term lung damage. Increased surveillance and diagnostics are crucial for better management and outcomes.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Lower respiratory tract infections (LRTIs) are a major cause of child morbidity and mortality globally, particularly in African children under five.
  • Human adenoviruses (HAdVs) are increasingly recognized as significant viral pathogens contributing to pediatric LRTIs, including fatal pneumonias.
  • The impact and epidemiology of HAdV infections in African children remain under-recognized, despite evidence of severe clinical manifestations and sequelae.

Purpose of the Study:

  • To review the epidemiology, clinical manifestations, sequelae, and treatment of adenovirus respiratory infections in African children.
  • To highlight the underappreciated role of HAdVs in pediatric LRTIs in Africa.
  • To identify gaps in knowledge and recommend strategies for improved surveillance and care.

Main Methods:

  • Systematic review of existing literature on HAdV infections in African children.
  • Analysis of epidemiological data on HAdV prevalence in pediatric LRTIs.
  • Synthesis of clinical findings, including manifestations, severity, and long-term sequelae.

Main Results:

  • HAdV is the third most common viral pathogen in fatal pneumonias among African children under five, accounting for 5.5% of deaths.
  • HAdV ranks second in hospital-associated viral pneumonia deaths in this demographic.
  • Disease-causing HAdV serotypes vary by region and have evolved over time; risk factors for severe disease and sequelae are not well-defined.

Conclusions:

  • Adenovirus infections pose a substantial threat to child lung health in Africa, leading to severe outcomes and chronic sequelae like bronchiectasis.
  • There is a critical need for scaled-up HAdV surveillance and consistent inclusion in LRTI assessments.
  • Expanded access to diagnostics and further research into HAdV epidemiology and clinical outcomes are essential for effective public health interventions.
Abstract

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
496
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
206
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
138
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
223